オダアヤコ｜明治薬科大学

研究分野

医療薬学

主な研究業績

Ultra-Sensitive Quantification of Coproporphyrin-I and -III in Human Plasma Using Ultra-Performance Liquid Chromatography Coupled to Quadrupole Time-of-Flight Mass Spectrometry. ACS Omega, 9, 47135-47144 (2024)

Negami J, Suzuki Y, Sato H, Toyama D, Tanaka R, Ono H, Oda A, Tatsuta R, Ozaki T, Shibata H, Itoh H, Ohno K.
Evaluation of intra‐ and inter‐individual variations in plasma belimumab concentrations in adult patients with systemic lupus erythematosus. Pharmacol Res Perspect, 12, e1255 (2024)

Yoshijima C, Suzuki Y, Tanaka R, Ono H, Oda A, Ozaki T, Shibata H, Itoh H, Ohno K.
Evaluation of the usefulness of plasma 4β‐hydroxycholesterol concentration normalized by 4α‐hydroxycholesterol for accurate CYP3A phenotyping. Clin Transl Sci, 17, e13768 (2024)

Oda A, Suzuki Y, Sato H, Koyama T, Nakatochi M, Momozawa Y, Tanaka R, Ono H, Tatsuta R, Ando T, Shin T, Wakai K, Matsuo K, h, Itoh H, Ohno K.
Usefulness of Belimumab in Adult Patients With Systemic Lupus Erythematosus Evaluated Using Single Indexes: A Meta-Analysis and Systematic Review. Curr Ther Res Clin Exp, 100, 100738 (2024)

Yoshijima C, Suzuki Y, Oda A, Tanaka R, Ono H, Itoh H, Ohno K.
Relationship of plasma 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid concentration with OATP1B activity in patients with chronic kidney disease. Clin Transl Sci, 17, e13731 (2024)

Ono H, Tanaka R, Suzuki Y, Oda A, Sato H, Tatsuta R, Ando T, Shin T, Ohno K, Itoh H.
Rapid and simple quantification of belimumab in human plasma using ultra-high performance liquid chromatography with tandem mass spectrometry. Clin Biochem, 124, 110706 (2024)

Yoshijima C, Suzuki Y, Tanaka R, Ono H, Oda A, Ozaki T, Shibata H, Itoh H, Ohno K.
Evaluation of effects of indoxyl sulfate and parathyroid hormone on CYP3A activity considering the influence of CYP3A5 gene polymorphisms. Br J Clin Pharmacol, 89, 3648-3658 (2023)

Oda A, Suzuki Y, Yoshijima C, Sato H, Tanaka R, Ono H, Tatsuta R, Ando T, Shin T, Itoh H, Ohno K.
Positive correlation between organic anion transporter 1B function indicated by plasma concentration of coproporphyrin-I and blood concentration of cyclosporin A in real-world patients. Br J Clin Pharmacol, 89, 1672-1681 (2023)

Watanabe T, Tanaka R, Suzuki Y, Sato H, Negami J, Yoshijima C, Oda A, Ono H, Tatsuta R, Ohno K, Itoh H.
Highly sensitive simultaneous quantification of indoxyl sulfate and 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid in human plasma using ultra-high performance liquid chromatography coupled with tandem mass spectrometry. J Sep Sci, 45, 1672-1682 (2022)

Oda A, Suzuki Y, Sato B, Sato H, Tanaka R, Ono H, Ando T, Shin T, Mimata H, Itoh H, Ohno K.
Sensitive UHPLC-MS/MS quantification method for 4β- and 4α-hydroxycholesterol in human plasma for accurate CYP3A phenotyping. J Lipid Res, 63, 100184 (2022)

Suzuki Y, Oda A, Negami J, Toyama D, Tanaka R, Ono H, Ando T, Shin T, Mimata H, Itoh H, Ohno K.

所属学協会

日本薬学会、日本医療薬学会、日本TDM学会、日本臨床薬理学会

受賞

2024年9月	22th International Congress of Therapeutic Drug Monitoring & Clinical Toxicology, Best Clinical Toxicology Poster Presentation
2022年5月	第38回日本TDM学会・学術大会優秀演題賞

社会・学術貢献活動

第34回⽇本医療薬学会年会実⾏委員

小田　絢子（オダアヤコ）

研究分野

主な研究業績

所属学協会

受賞

社会・学術貢献活動

おすすめコンテンツ